Prescription Sig and Duration for Bile Acid Sequestrants in Diarrhea
For cholestyramine: Start with 4 grams (one packet) once daily, taken with meals; titrate gradually every 3-7 days based on response up to a maximum of 24 grams daily divided in 2-4 doses; duration is indefinite with consideration for on-demand dosing once symptoms controlled. 1
For colesevelam (second-line): Prescribe 625 mg tablets, 3 tablets (1,875 mg) twice daily with meals for a total of 3.75 grams daily; no titration required; duration is indefinite with consideration for on-demand dosing once symptoms controlled. 1
Cholestyramine Dosing Details
Initial Prescription
- Starting dose: 4 grams once daily with a meal
- Sig: "Take one packet (4 grams) mixed in water or juice once daily with breakfast. Mix powder thoroughly before drinking."
- Titration schedule: Increase by 4 grams every 3-7 days as tolerated based on symptom response
- Maximum dose: 24 grams daily (divided into 2-4 doses)
- Typical effective range: 8-16 grams daily in divided doses
The Canadian Association of Gastroenterology guideline emphasizes gradual dose titration as a good practice statement to minimize side effects like constipation, bloating, and nausea 1. Studies show cholestyramine is typically started at 2-4 grams daily and titrated to clinical response with a maximum of 24 grams daily 1.
Duration Considerations
- Initial trial: Prescribe for 4-6 weeks to assess response
- Long-term management: Indefinite duration if effective
- On-demand option: After achieving symptom control, consider intermittent dosing rather than continuous daily use 1
Evidence suggests that some patients can maintain symptom control with on-demand therapy after initial response, though this is based on very low certainty evidence 1.
Colesevelam Dosing Details (Second-Line)
When to Use Colesevelam
Reserve colesevelam for patients who:
- Fail to respond to cholestyramine
- Cannot tolerate cholestyramine (unpalatability, side effects)
- Prefer tablet formulation over powder
The guideline consensus indicates colesevelam has a favorable benefit-risk profile and easier administration compared to cholestyramine, but should be reserved for second-line use due to limited clinical experience and higher cost 1.
Prescription Details
- Dose: 625 mg tablets, 3 tablets twice daily (total 3.75 grams daily)
- Sig: "Take 3 tablets (1,875 mg) by mouth twice daily with meals"
- Alternative dosing: 6 tablets once daily with a meal (per FDA labeling) 2
- No titration required: Start at full therapeutic dose 1
- Duration: Same as cholestyramine—initial 4-6 week trial, then indefinite if effective
Studies in bile acid diarrhea used colesevelam at 1,875 mg twice daily with success rates of approximately 57-73% 1, 3. A high-quality 2023 RCT showed 59-64% remission rates with colesevelam versus 13-16% with placebo 3.
Critical Timing and Administration Instructions
Medication Interactions
Both agents bind medications and vitamins—critical counseling points:
- Take other oral medications at least 1 hour before or 4-6 hours after bile acid sequestrants
- Fat-soluble vitamins (A, D, E, K) should be taken at least 4 hours before the sequestrant 2
- Particularly important for: thyroid medications, warfarin, digoxin, and oral contraceptives
Preparation Instructions for Cholestyramine
- Mix powder with 2-6 ounces of water, juice, or non-carbonated beverages
- Let stand 1-2 minutes, stir thoroughly
- Never take powder dry
- Can also mix with applesauce or pulpy fruits
Monitoring and Adjustment Strategy
Response Assessment Timeline
- Week 2-4: Assess initial response and tolerability
- Week 4-6: Determine if dose adjustment needed
- Week 8-12: Evaluate for complete/partial response versus treatment failure
Defining Treatment Response
- Complete response: Resolution of diarrhea (fewer than 3 bowel movements daily, no watery stools)
- Partial response: ≥50% reduction in stool frequency or improvement in consistency
- Treatment failure: <50% improvement after 6-8 weeks at adequate doses
Dose Titration for Cholestyramine
If inadequate response after 2 weeks at current dose:
- Increase by 4 grams daily
- Divide total daily dose into 2-3 administrations with meals
- Continue titration every 3-7 days until symptom control or maximum dose reached
- Most patients respond to 8-16 grams daily 1
Important Contraindications and Cautions
Avoid Bile Acid Sequestrants in:
- Extensive ileal resection (>100 cm): Risk of worsening steatorrhea and caloric loss 1
- Complete biliary obstruction
- Severe hypertriglyceridemia (>500 mg/dL): Both agents can increase triglycerides 2
Common Pitfalls
- Starting at too high a dose: Leads to intolerance and discontinuation—always start low
- Not spacing other medications: Results in reduced efficacy of concomitant drugs
- Inadequate mixing of powder: Causes esophageal irritation or obstruction risk
- Premature discontinuation: Patients may stop due to initial bloating before therapeutic benefit achieved
Side Effect Management
Expected Adverse Effects
- Constipation (most common—may require dose reduction)
- Bloating and abdominal distension
- Nausea
- Flatulence
These are generally mild and transient. In the 2023 RCT, adverse event rates were similar between colesevelam and placebo (40% vs 36%) 1. If constipation occurs, reduce dose temporarily until resolved, then retry at lower dose 4.
When to Discontinue
- Severe abdominal pain (concern for bowel obstruction)
- Severe persistent constipation despite dose reduction
- Signs of pancreatitis (if triglycerides elevated)
- Intolerable gastrointestinal symptoms after 2-4 weeks
Sample Prescriptions
Cholestyramine (First-Line)
Cholestyramine 4 gram powder packets
Sig: Mix 1 packet in 4-6 oz water or juice once daily with breakfast
Dispense: #30 packets
Refills: 2
Duration: Take daily; may increase dose as directed by physicianColesevelam (Second-Line)
Colesevelam 625 mg tablets
Sig: Take 3 tablets by mouth twice daily with meals
Dispense: #180 tablets
Refills: 2
Duration: Take daily as directedThe evidence strongly supports starting with cholestyramine as first-line therapy due to greater clinical experience and lower cost, reserving colesevelam for patients who fail or cannot tolerate cholestyramine 1. Both agents show similar efficacy rates (73-74% good/partial response) when used appropriately 1.